Brief: Twist Bioscience Q3 EPS USD -1.01

Twist Bioscience

04/08/2023 12:30

Aug 04 (Reuters) - Twist Bioscience Q3 net income USD -57.395 million.
* Q3 revenue USD 63.74 million vs. IBES estimate USD 60.5 million
* Outlook FY Revenue USD 241-242 Million
* Outlook FY Capex USD 35 Million
* Outlook Q4 Revenue USD 63-64 Million
* Outlook Q4 Gross Margin 36%
* Outlook FY Gross Margin 36%